Matches in Wikidata for { <http://www.wikidata.org/entity/Q98503315> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q98503315 description "2020 թվականի հունիսի 11-ին հրատարակված գիտական հոդված" @default.
- Q98503315 description "article scientifique publié en 2020" @default.
- Q98503315 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q98503315 description "im Juni 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q98503315 description "scientific article published on 11 June 2020" @default.
- Q98503315 description "wetenschappelijk artikel" @default.
- Q98503315 description "наукова стаття, опублікована 11 червня 2020" @default.
- Q98503315 name "Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches" @default.
- Q98503315 name "Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches" @default.
- Q98503315 type Item @default.
- Q98503315 label "Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches" @default.
- Q98503315 label "Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches" @default.
- Q98503315 prefLabel "Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches" @default.
- Q98503315 prefLabel "Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches" @default.
- Q98503315 P1433 Q98503315-27CAE6FB-B518-48A8-B04A-54EDB0DCC36D @default.
- Q98503315 P1476 Q98503315-9C971C3B-04B2-499D-9692-218D34766B6F @default.
- Q98503315 P2093 Q98503315-3B868AF3-5907-4FA9-B05E-EFD65ACB0E8B @default.
- Q98503315 P2093 Q98503315-68CFDCC3-F3D8-4D61-8BC2-E8261EC4097E @default.
- Q98503315 P2093 Q98503315-EE1959AC-1BBD-4370-AFAF-68FC57C9F523 @default.
- Q98503315 P304 Q98503315-5D1D92B1-AAC5-4AC9-84D6-89F0EFB1FD58 @default.
- Q98503315 P31 Q98503315-0EAA4A3F-6282-4175-9B36-8303FF5AFBD8 @default.
- Q98503315 P356 Q98503315-6D2E1CE5-F65E-4374-B452-91023EAF8DD9 @default.
- Q98503315 P433 Q98503315-94729A0E-0C6F-4AEF-86E0-EF2C59C93670 @default.
- Q98503315 P478 Q98503315-7A7D7712-0A9B-4ED7-80B9-9AA1FCEA2968 @default.
- Q98503315 P577 Q98503315-DE481A81-E24A-4827-BDF3-6244DDC128A7 @default.
- Q98503315 P698 Q98503315-E23E91CB-9B7F-477A-8AE8-0F2D8D690DE2 @default.
- Q98503315 P921 Q98503315-049C1B1F-7F32-4091-A184-EE29C49502FC @default.
- Q98503315 P356 S13340-020-00444-8 @default.
- Q98503315 P698 32802705 @default.
- Q98503315 P1433 Q27727408 @default.
- Q98503315 P1476 "Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches" @default.
- Q98503315 P2093 "Daisuke Koya" @default.
- Q98503315 P2093 "Munehiro Kitada" @default.
- Q98503315 P2093 "Taro Hirai" @default.
- Q98503315 P304 "245-251" @default.
- Q98503315 P31 Q13442814 @default.
- Q98503315 P356 "10.1007/S13340-020-00444-8" @default.
- Q98503315 P433 "3" @default.
- Q98503315 P478 "11" @default.
- Q98503315 P577 "2020-06-11T00:00:00Z" @default.
- Q98503315 P698 "32802705" @default.
- Q98503315 P921 Q3025883 @default.